ahlam1399
07-25-2015, 12:29 AM
UPDATE 1-FDA approves Sa**fi/Regeneron cholesterol drug with limits
WASHINGTON, July 24 (Reuters) - The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sa**fi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4869eca9/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x41l95xVH3o:SLksLonr0tU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x41l95xVH3o:SLksLonr0tU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x41l95xVH3o
WASHINGTON, July 24 (Reuters) - The U.S. Food and Drug Administration approved a potent new cholesterol-lowering drug from Sa**fi SA and Regeneron Pharmaceuticals Inc on Friday but limited its approved use to patients with a hereditary form of the condition and those with cardiovascular disease.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4869eca9/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x41l95xVH3o:SLksLonr0tU:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=x41l95xVH3o:SLksLonr0tU:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=x41l95xVH3o:SLksLonr0tU:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/x41l95xVH3o